Calidi Biotherapeutics Inc. (CLDI) Live Share Price, Invest From India

Calidi Biotherapeutics Inc. Stock Performance

as on May 14, 2026 at 4:13 am IST

Day's Low
Day's High
$0.18
Day's Price Range
$0.20
$0.19
5.26%
Downside
5.26%
Upside
52 Week's Low
52 Week's High
$0.19
52-Week Price Range
$19.20
$0.19
2.63%
Downside
10005.26%
Upside

Calidi Biotherapeutics Inc. share price movements today

Previous Close: $0.18
Open: $0.19
Volume: 1.8M
Day's Low - High: $0.18 - $0.20
52 Week Low - High: $0.19 - $19.20

Calidi Biotherapeutics Inc. Historical Returns

1 Month Return: -34.28 %
3 Month Return: -76.36 %
1 Year Return: -96.47 %
3 Year Return: 0 %
5 Year Return: 0 %

Calidi Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Calidi Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0M

EPS (TTM)

-7.4403

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-18.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-700.65%

Calidi Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Calidi Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Calidi Biotherapeutics Inc.	BUY	$3.0M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Calidi Biotherapeutics Inc. Stock including INR - Dollar returns

The Calidi Biotherapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Calidi Biotherapeutics Inc. investment value today

Current value as on today

₹4,069

Returns

-₹95,931

(-95.93%)

Returns from Calidi Biotherapeutics Inc. Stock

-₹96,374 (-96.37%)

Dollar Impact

₹444 (+0.44%)

Analyst Recommendation on Calidi Biotherapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Calidi Biotherapeutics Inc.. Average target price of $120

Calidi Biotherapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Calidi Biotherapeutics Inc..

What analysts predicted

99.84%UPSIDE

Target Price

$120

Current Price

$0.19

Analyzed by

8 Analysts

Target

$120.00

Calidi Biotherapeutics Inc. target price $120, a slight upside of 99.84% compared to current price of $0.19. According to 8 analysts rating.

Indian Investors' Interest in Calidi Biotherapeutics Inc. Stock

Search interest for Calidi Biotherapeutics Inc. Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-16% versus previous 30 day period

Calidi Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	1	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-7	-9	-6	-5	-5	-4	-5	-5	-5	-4
EBITDA	-1	-7	-6	-5	-4	-3	-4	-5	-4	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-8	-7	-5	-5	-4	-5	-5	-5	-4
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-2	-8	-7	-5	-5	-4	-4	-5	-5	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-272.41%	0.00%	0.00%	0.00%	0.00%

Calidi Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	-	-	-
Gross Profit	-	0	0	-1	-1	-1
Operating Income	-6	-10	-23	-28	-21	-20
EBITDA	-6	-9	-24	-24	-19	-18
Interest Expense	0	0	0	3	0	0
Depreciation	0	0	0	1	1	1
Income Before Tax	-7	3	-25	-29	-22	-20
Income Tax Expense	0	0	0	0	0	0
Net Income	-7	-10	-25	-29	-22	-19
Net Profit Margin	0.00%	-2434.97%	-56504.44%	0.00%	0.00%	0.00%

Calidi Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-8	-7	-5	-5	-4	-5	-5	-5	-4
Operating Cash Flow	-5	-3	-3	-4	-5	-7	-4	-4	-5
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	-2	3	3	6	13	8	0	9	0
Change in Cash	-8	0	0	1	7	0	-5	5	-4

Calidi Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-10	-25	-29	-22	-25
Operating Cash Flow	-7	-13	-26	-19	-21
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	9	12	29	27	17
Change in Cash	1	0	1	7	-3

Insights on Calidi Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 136.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CLDI stock has moved down by -15.9%

About Calidi Biotherapeutics Inc.

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Organisation	Calidi Biotherapeutics Inc.
Headquarters	4475 Executive Drive, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Dr. Eric E. Poma Ph.D.
E-voting on shares	Click here to vote

Key Management of Calidi Biotherapeutics Inc.

Name	Title
Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.	Head of Technical Operations & Chief Scientific Officer
Dr. Guy Travis Clifton M.D.	Chief Medical Officer
Dr. Eric E. Poma Ph.D.	CEO & Director
Mr. Andrew C. Jackson	CFO & Corporate Secretary

FAQs

What is Calidi Biotherapeutics Inc. share price today?

Calidi Biotherapeutics Inc. share price today is $0.19 as on May 13, 2026 at 10:43 pm IST. Calidi Biotherapeutics Inc. share today touched a day high of $0.2 and a low of $0.18.

What is the 52 week high and 52 week low for Calidi Biotherapeutics Inc. share?

Calidi Biotherapeutics Inc. share touched a 52 week high of $19.2 on July 9, 2025 and a 52 week low of $0.19 on May 12, 2026. Calidi Biotherapeutics Inc. stock price today i.e. May 13, 2026 at 10:43 pm IST is trending at $0.19,which is 99.01% down from its 52 week high and 2.70% up from its 52 week low.

What is Calidi Biotherapeutics Inc.'s market capitalisation today?

Calidi Biotherapeutics Inc. market capitalisation is $0.00T as on May 13, 2026 at 10:43 pm IST.

How to invest in Calidi Biotherapeutics Inc. Stock (CLDI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Calidi Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Calidi Biotherapeutics Inc. Shares that will get you 7.8947 shares as per Calidi Biotherapeutics Inc. share price of $0.19 per share as on May 13, 2026 at 10:43 pm IST.

What is the minimum amount required to buy Calidi Biotherapeutics Inc. Stock (CLDI) from India?

Indian investors can start investing in Calidi Biotherapeutics Inc. (CLDI) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 10:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Calidi Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 10:43 pm IST). Based on Calidi Biotherapeutics Inc. share’s latest price of $0.19 as on May 13, 2026 at 10:43 pm IST, you will get 52.6316 shares of Calidi Biotherapeutics Inc.. Learn more about fractional shares .